Last edition
News about "Sun Pharma "
Trump's 100 Percent Pharma Tariff to Have Twofold Impact on Indian Drugmakers
The proposed tariffs target only branded and patented medicines, leaving India’s generic exports largely unaffected. While companies making branded drugs for the US may face challenges, domestic generic producers could benefit from increased demand for affordable alternatives.
Sun Pharma | 29/09/2025 | By Dineshwori | 307
Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business
Emcure Pharmaceuticals Ltd. has appointed R.S. Vasan as President – India Business and Senior Management Personnel (SMP).
Sun Pharma | 16/07/2025 | By Dineshwori | 233
Sun Pharma to Acquire Checkpoint Therapeutics
Checkpoint has received approval from the US Food & Drug Administration (FDA) for UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation.
Sun Pharma | 10/03/2025 | By Aishwarya | 148
Sun Pharma Presents New Clinical Efficacy and Safety Data in Dermatology at EADV Congress
The company will also share results in two additional posters for deuruxolitinib, which showed clinically meaningful improvement in anxiety and depression among patients taking deuruxolitinib to treat their severe AA (P2022) as well as dose optimization for deuruxolitinib at 8 mg (P2081).
Sun Pharma | 27/09/2024 | By Aishwarya | 724
Sun Pharma and Moebius Medical Receive FTD for MM-II for Treatment of Osteoarthritis Knee Pain
Sun Pharma and Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to MM-II (Large Liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain.
Sun Pharma | 07/09/2024 | By Aishwarya | 257
Sun Pharma Signs Non-Exclusive Patent Licensing Deal with Takeda for Vonoprazan
Sun Pharma has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Ltd. to commercialise Vonoprazan tablets 10 mg, 20 mg in India under the brand name Voltapraz.
Sun Pharma | 24/06/2024 | By Aishwarya | 864
Sun Pharma | 22/08/2023 | By Sudeep Soparkar | 674
IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm
Sun Pharma | 14/06/2023 | By Sudeep Soparkar | 874
Sun Pharma recalls more than 34,000 bottles of generic medication in US
The lot was manufactured at the Mumbai-based drugmaker's Halol-based manufacturing facility in Gujarat that has failed dissolution testing
Sun Pharma | 13/02/2023 | By Sudeep Soparkar | 758
Sun Pharma in agreement with Cosmo Pharma
Announce territory expansion of license and supply agreements for WINLEVI to include Japan, Australia, New Zealand, Brazil, Mexico and Russia
<br />
Sun Pharma | 26/07/2022 | By Sudeep Soparkar | 916
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy